Dr. Matthew C. Bunte, MD

Dr. Bunte practices at Saint Luke's East Hospital in Lee'S Summit, Missouri, part of BJC Health.

Dr. Bunte's NPI, 1518039239, was assigned on November 15, 2006. Dr. Bunte graduated from University of Minnesota Medical School in 2005. Dr. Bunte holds Missouri license 2014017700.

Dr. Bunte's primary practice is Saint Luke's East Hospital, at 100 N E Saint Luke's Boulevard, Lee'S Summit, MO 64086 in Jackson County. The practice phone is (816) 347-5000. Dr. Bunte also practices at Saint Lukes East Hospital, 80 NE St Lukes Blvd, Lee'S Summit, MO 64086.

Dr. Bunte's primary practice is Saint Luke's East Hospital in Lee'S Summit, Missouri, part of BJC Health. Dr. Bunte is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Hannibal Regional Medical Group. Dmand AI also links Dr. Bunte to 4 more hospitals, 9 medical groups and 8 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bunte practices, 14 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bunte's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bunte is licensed in Missouri.

CMS data shows 851 Medicare services from Dr. Bunte across 16 procedure codes in 2024, for 516 Medicare patients. Medicare paid $54,355 for them.

CMS counts 516 Medicare patients who saw Dr. Bunte in 2024. The largest group is 75 to 84, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bunte's median patient age at 71, with 47% women.

In 2024, Dr. Bunte wrote 4,147 Medicare Part D claims for 566 patients. 81% of them were for generic drugs. CMS names the drug for 3,944 of them, across 43 drugs with 11 or more claims each, at $832,255 in total drug cost. In 2023, CMS named 3,679 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Bunte for performance year 2024, reported as part of a group. Dr. Bunte accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Bunte, published from 2012 to 2024. 2023 was the busiest year, with 8. The most frequent topics are Peripheral Arterial Disease, Pulmonary Embolism and Thrombolytic Therapy. Dr. Bunte has published most often in Vasc Med. Dr. Bunte's most frequent co-authors are Mehdi H. Shishehbor, DO, Ahmed Elsaid Elkaryoni, MD and Hamid Reza Mojibian, MD.

Dmand AI links Dr. Bunte to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia.

CMS Open Payments shows 554 general payments to Dr. Bunte from 35 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. ShockWave Medical, Inc paid the most, $101,425.

Dr. Bunte graduated from University of Minnesota Medical School in 2005.